Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Garg

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
BMJ Open|September 3, 2021
Attaining a British consensus statement on managing idiopathic congenital talipes equinovarus (CTEV) through a Delphi process: a study protocolYael Gelfer, Jose Blanco, Amanda Trees, et al.
Cureus|September 2, 2025
Evaluation of Effectiveness and Tolerability of Saroglitazar in Metabolic Disease Patients of India: A Retrospective, Observational, Electronic Medical Record-Based Real-World Evidence StudySambit Das, Sunil Gupta, Tejal Lathia, et al.
Journal of Medicinal Chemistry|March 28, 2020
Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic StabilityGergana Popova, Marcus J G W Ladds, Lars Johansson, et al.
Journal of Medicinal Chemistry|April 18, 2003
Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1Liu Ye, Yi-Lin Li, Karin Mellström, et al.
European Journal of Biochemistry|April 16, 2003
Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitorsHans O Andersson, Kerstin Fridborg, Seved Löwgren, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2007
Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141Neeraj Garg, Yi-Lin Li, Ana Maria Garcia Collazo, et al.
Nature Cancer|March 1, 2022
Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stressNadilly Bonagas, Nina M S Gustafsson, Martin Henriksson, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
BMJ Open|September 3, 2021
Attaining a British consensus statement on managing idiopathic congenital talipes equinovarus (CTEV) through a Delphi process: a study protocolYael Gelfer, Jose Blanco, Amanda Trees, et al.
Cureus|September 2, 2025
Evaluation of Effectiveness and Tolerability of Saroglitazar in Metabolic Disease Patients of India: A Retrospective, Observational, Electronic Medical Record-Based Real-World Evidence StudySambit Das, Sunil Gupta, Tejal Lathia, et al.
Journal of Medicinal Chemistry|March 28, 2020
Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic StabilityGergana Popova, Marcus J G W Ladds, Lars Johansson, et al.
Journal of Medicinal Chemistry|April 18, 2003
Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1Liu Ye, Yi-Lin Li, Karin Mellström, et al.
European Journal of Biochemistry|April 16, 2003
Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitorsHans O Andersson, Kerstin Fridborg, Seved Löwgren, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2007
Thyroid receptor ligands. Part 8: Thyromimetics derived from N-acylated-alpha-amino acid derivatives displaying modulated pharmacological selectivity compared with KB-141Neeraj Garg, Yi-Lin Li, Ana Maria Garcia Collazo, et al.
Nature Cancer|March 1, 2022
Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stressNadilly Bonagas, Nina M S Gustafsson, Martin Henriksson, et al.
Pageof 5